Close to 90 percent of patients with unresectable (inoperable) desmoplastic melanoma, a rare form of skin cancer, saw their cancer improve after treatment with the immunotherapy drug pembrolizumab in a recent clinical trial. These results from the S1512 trial are being delivered in an oral presentation at the clinical trials plenary session of the 2023 annual meeting of the American Association for Cancer Research (AACR) in Orlando, Florida, on April 16th.
Adding a personalized cancer vaccine to the blockbuster drug Keytruda kept more melanoma patients in remission than the immune therapy alone, co-developers Moderna Inc. and Merck & Co. said in
Study: Vaccine helps drug keep melanoma patients cancer-free islandpacket.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from islandpacket.com Daily Mail and Mail on Sunday newspapers.
MONDAY, March 6, 2023 (HealthDay News) A tweak in timing may make an immune-system therapy much more effective for patients undergoing surgery for advanced melanoma, a new clinical trial